AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 51 filers reported holding AGILE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $176,000 | -61.6% | 841,118 | -10.4% | 0.00% | – |
| Q4 2021 | $458,000 | -49.3% | 938,561 | -0.2% | 0.00% | -100.0% |
| Q3 2021 | $903,000 | -54.8% | 939,979 | -37.5% | 0.00% | 0.0% |
| Q2 2021 | $2,000,000 | +15.3% | 1,504,056 | +141.0% | 0.00% | -50.0% |
| Q2 2020 | $1,735,000 | -32.8% | 624,190 | -55.0% | 0.00% | -66.7% |
| Q1 2020 | $2,582,000 | +870.7% | 1,388,336 | +1203.8% | 0.01% | – |
| Q4 2019 | $266,000 | +52.0% | 106,481 | -28.1% | 0.00% | – |
| Q3 2019 | $175,000 | +56.2% | 148,138 | +256.0% | 0.00% | – |
| Q4 2017 | $112,000 | -82.5% | 41,607 | -71.0% | 0.00% | -100.0% |
| Q3 2017 | $639,000 | +30.9% | 143,326 | +10.0% | 0.00% | 0.0% |
| Q2 2017 | $488,000 | +152.8% | 130,256 | +525.7% | 0.00% | – |
| Q1 2015 | $193,000 | -80.2% | 20,819 | -81.4% | 0.00% | -100.0% |
| Q2 2014 | $975,000 | – | 111,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
| CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
| Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
| Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
| INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
| Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
| Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
| Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |